학술논문
End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Document Type
Article
Author
Source
Ophthalmology Retina; 20210101, Issue: Preprints
Subject
Language
ISSN
24687219; 24686530
Abstract
To report the end-of-study results from the Ladder clinical trial of the Port Delivery System with ranibizumab (PDS) for the treatment of neovascular age-related macular degeneration (nAMD).